Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117365) titled 'A Study on the Application of Femoral Nerve Block with Different Concentrations of Liposomal Bupivacaine in the Perioperative Period of Patients with Femoral Shaft Fractures' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ethics Committee of the 960th Hospital of the Chinese People's Liberation Army
Condition:
Femoral shaft fracture
Intervention:
Group 1:Ropivacaine Hydrochloride 0.25%
Group 2:Bupivacaine Liposome 0.665%
Group 3:Bupivacaine Liposome 0.887%
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-01-04
Target Sample Size: Group...